9
Disclosures
Feb 6, 2026 — May 20, 2026
Date Range
GROWTH
Market Segment
Pharmaceutical
Sector

Disclosures

DateTypeHeadlinePDF
May 20 Other Tsubota Laboratory to Appoint New Auditor Starting June 23, 2026 PDF
May 20 Other Tsubota Laboratory to Hold Annual Shareholders Meeting on June 23 PDF
May 14 Other Tsubota Laboratory Reports Second Consecutive Quarterly Loss Amid Revenue Slump PDF
Mar 23 Other Tsubota Laboratory: to Amend ETF Provisions Effective April 1 PDF
Feb 13 Earnings Tsubota Laboratory Incorporated Reports Q3 Revenue of 145 million, Down 82% PDF
Feb 6 Other Tsubota Lab Provides Positive Interpretation of TLG-001 Clinical Trial Results Despite Primary Endpoint Miss PDF
Feb 6 Other Tsubota Lab Reports Positive Preliminary Results for TLG-001 Device in Pediatric Myopia Study PDF
Feb 6 Other Tsubota Laboratory to Cut Executive Compensation Amid Earnings Forecast Downgrade PDF
Feb 6 Forecast FY2026/3 Full-Year Earnings Forecast Downward Revision PDF

Disclosure Types

Other: 7 Earnings: 1 Forecast: 1